Bruker (BRKR) Non Operating Investment Income (2026)
Bruker's (BRKR) quarterly Non Operating Investment Income came in at $12.2 million in Q1 2026.
Powered by 
Analysis
Bruker (BRKR) Non Operating Investment Income (2026) Analysis & Trends
Bruker (BRKR) has reported Non Operating Investment Income for 1 consecutive years, with $12.2 million the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 458.00 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | - |